260 related articles for article (PubMed ID: 16391368)
1. Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.
Travis LB; Rabkin CS; Brown LM; Allan JM; Alter BP; Ambrosone CB; Begg CB; Caporaso N; Chanock S; DeMichele A; Figg WD; Gospodarowicz MK; Hall EJ; Hisada M; Inskip P; Kleinerman R; Little JB; Malkin D; Ng AK; Offit K; Pui CH; Robison LL; Rothman N; Shields PG; Strong L; Taniguchi T; Tucker MA; Greene MH
J Natl Cancer Inst; 2006 Jan; 98(1):15-25. PubMed ID: 16391368
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of second primary cancers.
Travis LB
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2020-6. PubMed ID: 17057028
[TBL] [Abstract][Full Text] [Related]
3. Second malignant neoplasms and cardiovascular disease following radiotherapy.
Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
J Natl Cancer Inst; 2012 Mar; 104(5):357-70. PubMed ID: 22312134
[TBL] [Abstract][Full Text] [Related]
4. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
Elena JW; Travis LB; Simonds NI; Ambrosone CB; Ballard-Barbash R; Bhatia S; Cerhan JR; Hartge P; Heist RS; Kushi LH; Lash TL; Morton LM; Onel K; Pierce JP; Robison LL; Rowland JH; Schrag D; Sellers TA; Seminara D; Shu XO; Thomas NE; Ulrich CM; Freedman AN
J Natl Cancer Inst; 2013 Jan; 105(2):85-94. PubMed ID: 23197494
[TBL] [Abstract][Full Text] [Related]
5. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
6. Second malignant neoplasms and cardiovascular disease following radiotherapy.
Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
Health Phys; 2014 Feb; 106(2):229-46. PubMed ID: 24378498
[TBL] [Abstract][Full Text] [Related]
7. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.
Travis LB; Demark Wahnefried W; Allan JM; Wood ME; Ng AK
Nat Rev Clin Oncol; 2013 May; 10(5):289-301. PubMed ID: 23529000
[TBL] [Abstract][Full Text] [Related]
8. Therapy-associated solid tumors.
Travis LB
Acta Oncol; 2002; 41(4):323-33. PubMed ID: 12234023
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.
Bhatia S
Cancer; 2015 Mar; 121(5):648-63. PubMed ID: 25355167
[TBL] [Abstract][Full Text] [Related]
10. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
[TBL] [Abstract][Full Text] [Related]
11. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
12. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to radiogenic cancer in humans.
Allan JM
Health Phys; 2008 Nov; 95(5):677-86. PubMed ID: 18849702
[TBL] [Abstract][Full Text] [Related]
14. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
15. Second primary cancer due to radiotherapy and chemotherapy.
Manavoğlu O; Orhan B; Evrensel T; Karabulut Y; Ozkocaman V; Ozyardimci C
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):275-8. PubMed ID: 9216821
[TBL] [Abstract][Full Text] [Related]
16. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment.
Tukenova M; Diallo I; Hawkins M; Guibout C; Quiniou E; Pacquement H; Dhermain F; Shamsaldin A; Oberlin O; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):707-15. PubMed ID: 20200431
[TBL] [Abstract][Full Text] [Related]
17. Second malignant neoplasms: assessment and strategies for risk reduction.
Wood ME; Vogel V; Ng A; Foxhall L; Goodwin P; Travis LB
J Clin Oncol; 2012 Oct; 30(30):3734-45. PubMed ID: 23008293
[TBL] [Abstract][Full Text] [Related]
18. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of therapy-related carcinogenesis.
Allan JM; Travis LB
Nat Rev Cancer; 2005 Dec; 5(12):943-55. PubMed ID: 16294218
[TBL] [Abstract][Full Text] [Related]
20. Cancer research. Childhood's cures haunted by adulthood's 'late effects'.
Marder J
Science; 2010 Jun; 328(5985):1474-5. PubMed ID: 20558684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
